Screener
AnaptysBio, Inc. ANAB Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | March 31, 2026(unaudited) | December 31, 2025 |
|---|---|---|
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $7,517 | $3,871 |
| Accrued expenses | 32,065 | 32,674 |
| Current portion of operating lease liability | 2,120 | 2,080 |
| Total current liabilities | 41,702 | 38,625 |
| Liability related to sale of future royalties | 263,742 | 276,528 |
| Operating lease liability, net of current portion | 11,493 | 12,032 |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s accrued expenses?
- AnaptysBio, Inc. (ANAB) reported accrued expenses of $32.07M in Q1 2026.
- How has AnaptysBio, Inc.'s accrued expenses changed year-over-year?
- AnaptysBio, Inc.'s accrued expenses decreased by 10.8% year-over-year, from $35.95M to $32.07M.
- What is the long-term trend for AnaptysBio, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s accrued expenses has grown at a 16.4% compound annual growth rate (CAGR), from $15.26M to $32.67M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about AnaptysBio, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude